Latest Financial Health News

Eastern Metals Limited will have its trading suspension lifted on 9 January 2026, marking its return to the ASX after meeting key listing requirements.

Kingsgate Consolidated has dramatically reduced its borrowings by 68% through a new US$25 million standby loan facility, marking a significant step in its balance sheet de-gearing strategy.

Greatland Resources has reported a robust December quarter with gold and copper production rising alongside a significant cash increase, all while maintaining a debt-free balance sheet.

Elanor Investors Group has extended the deadline for dispatching its Notice of Meeting related to the Rockworth Capital Partners transaction, with the Extraordinary General Meeting now expected in early February 2026.

Globe Metals & Mining has issued over 56 million shares to Director Bo Tan, settling nearly all of an outstanding loan and achieving a fully debt-free status. This financial milestone positions the company strongly for advancing its Kanyika Niobium Project.

Centuria Capital Group has announced an ordinary fully franked dividend of AUD 0.052 per security for the half-year ending December 2025, signaling steady income for investors.

Infratil Limited has achieved a significant milestone with S&P Global Ratings assigning it a BBB+ investment grade credit rating, signaling strong financial health and promising future expansion opportunities.

Little Green Pharma welcomes a landmark US Executive Order directing cannabis rescheduling, a move poised to reshape the global medicinal cannabis landscape.

Stockland has announced an estimated ordinary dividend of AUD 0.09 per security for the six months ending December 2025, payable in February 2026, alongside a Dividend Reinvestment Plan offering a 1% discount.

Assetora Limited has obtained a Supreme Court injunction restraining external receivers, allowing its directors to maintain control while agreeing on payments to noteholders.

DGL Group Limited has secured an extension of its syndicated debt facility to March 2027 and received a waiver protecting it from default amid its ASX suspension. The company anticipates its securities will be reinstated on the ASX by early 2026 following a half-year audit.

Bapcor Limited has obtained unanimous lender approval to temporarily ease its Net Leverage Ratio covenant, supporting its ongoing turnaround efforts through mid-2026.